Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats

M. Fujiwara, Y. Sakurai, Y. Kiyota, T. Shimazoe, H. Ohta, Shigenobu Shibata, S. Ueki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Behavioral effects of amantadine, especially on abnormal behavior in mice and rats, were reevaluated, in comparison with those of tricyclic antidepressants, methamphetamine and L-DOPA. 1) Amantadine at 10 ~ 50 mg/kg i.p., tended to decrease ambulation and rearing in rats and mice. The drug at 50 mg/kg i.p., caused piloerection and hyperirritability and at doses over 80 mg/kg, i.p., it impaired coordinated motor activity in rats. 2) Amantadine inhibited methamphetamine-induced hyperactivity, but apomorphine-induced stereotyped behavior was unaffected in rats. 3) Amantadine was equipotent to imipramine in suppressing haloperidol-induced catalepsy in rats, but L-DOPA was without effect. On the other hand, amantadine was 40 and 400 times as potent as imipramine and L-DOPA, respectively, in suppressing Δ9-tetrahydrocannabinol (THC)-induced catalepsy in rats. 4) Amantadine was as potent as imipramine in suppressing the muricide of olfactory bulbectomized rats, but was 3.5, 8.8 and 225.5 times as potent as methamphetamine, imipramine and L-DOPA, respectively, in inhibiting THC-induced reversible muricide in rats. 5) amantadine at 50 mg/kg did not elicit circling behavior in the rat with unilateral nigral lesion induced by 6-hydroxydopamine. 6) Amantadine at high doses caused irritable aggression characterized by squealing in rats pretreated with intraventricular 6-hydroxydopamine. The most important characteristic of amantadine is its prominent effect suppressing the THC-induced catalepsy and muricide. This may be a reflection of the feature of amantadine activating the dopaminergic as well as the serotonergic systems.

Original languageEnglish
Pages (from-to)259-274
Number of pages16
JournalFolia Pharmacologica Japonica
Volume85
Issue number4
Publication statusPublished - 1985
Externally publishedYes

Fingerprint

Amantadine
Pharmacology
Imipramine
Catalepsy
Dronabinol
Methamphetamine
Oxidopamine
Piloerection
Stereotyped Behavior
Apomorphine
Tricyclic Antidepressive Agents
Substantia Nigra
Haloperidol
Aggression
Walking
Motor Activity

ASJC Scopus subject areas

  • Pharmacology

Cite this

Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats. / Fujiwara, M.; Sakurai, Y.; Kiyota, Y.; Shimazoe, T.; Ohta, H.; Shibata, Shigenobu; Ueki, S.

In: Folia Pharmacologica Japonica, Vol. 85, No. 4, 1985, p. 259-274.

Research output: Contribution to journalArticle

Fujiwara, M, Sakurai, Y, Kiyota, Y, Shimazoe, T, Ohta, H, Shibata, S & Ueki, S 1985, 'Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats', Folia Pharmacologica Japonica, vol. 85, no. 4, pp. 259-274.
Fujiwara, M. ; Sakurai, Y. ; Kiyota, Y. ; Shimazoe, T. ; Ohta, H. ; Shibata, Shigenobu ; Ueki, S. / Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats. In: Folia Pharmacologica Japonica. 1985 ; Vol. 85, No. 4. pp. 259-274.
@article{60d522960702469fb6ed8547dee507c1,
title = "Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats",
abstract = "Behavioral effects of amantadine, especially on abnormal behavior in mice and rats, were reevaluated, in comparison with those of tricyclic antidepressants, methamphetamine and L-DOPA. 1) Amantadine at 10 ~ 50 mg/kg i.p., tended to decrease ambulation and rearing in rats and mice. The drug at 50 mg/kg i.p., caused piloerection and hyperirritability and at doses over 80 mg/kg, i.p., it impaired coordinated motor activity in rats. 2) Amantadine inhibited methamphetamine-induced hyperactivity, but apomorphine-induced stereotyped behavior was unaffected in rats. 3) Amantadine was equipotent to imipramine in suppressing haloperidol-induced catalepsy in rats, but L-DOPA was without effect. On the other hand, amantadine was 40 and 400 times as potent as imipramine and L-DOPA, respectively, in suppressing Δ9-tetrahydrocannabinol (THC)-induced catalepsy in rats. 4) Amantadine was as potent as imipramine in suppressing the muricide of olfactory bulbectomized rats, but was 3.5, 8.8 and 225.5 times as potent as methamphetamine, imipramine and L-DOPA, respectively, in inhibiting THC-induced reversible muricide in rats. 5) amantadine at 50 mg/kg did not elicit circling behavior in the rat with unilateral nigral lesion induced by 6-hydroxydopamine. 6) Amantadine at high doses caused irritable aggression characterized by squealing in rats pretreated with intraventricular 6-hydroxydopamine. The most important characteristic of amantadine is its prominent effect suppressing the THC-induced catalepsy and muricide. This may be a reflection of the feature of amantadine activating the dopaminergic as well as the serotonergic systems.",
author = "M. Fujiwara and Y. Sakurai and Y. Kiyota and T. Shimazoe and H. Ohta and Shigenobu Shibata and S. Ueki",
year = "1985",
language = "English",
volume = "85",
pages = "259--274",
journal = "Nihon yakurigaku zasshi. Folia pharmacologica Japonica",
issn = "0015-5691",
publisher = "Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - Behavioral pharmacology of amantadine with special reference to the effect on abnormal behavior in mice and rats

AU - Fujiwara, M.

AU - Sakurai, Y.

AU - Kiyota, Y.

AU - Shimazoe, T.

AU - Ohta, H.

AU - Shibata, Shigenobu

AU - Ueki, S.

PY - 1985

Y1 - 1985

N2 - Behavioral effects of amantadine, especially on abnormal behavior in mice and rats, were reevaluated, in comparison with those of tricyclic antidepressants, methamphetamine and L-DOPA. 1) Amantadine at 10 ~ 50 mg/kg i.p., tended to decrease ambulation and rearing in rats and mice. The drug at 50 mg/kg i.p., caused piloerection and hyperirritability and at doses over 80 mg/kg, i.p., it impaired coordinated motor activity in rats. 2) Amantadine inhibited methamphetamine-induced hyperactivity, but apomorphine-induced stereotyped behavior was unaffected in rats. 3) Amantadine was equipotent to imipramine in suppressing haloperidol-induced catalepsy in rats, but L-DOPA was without effect. On the other hand, amantadine was 40 and 400 times as potent as imipramine and L-DOPA, respectively, in suppressing Δ9-tetrahydrocannabinol (THC)-induced catalepsy in rats. 4) Amantadine was as potent as imipramine in suppressing the muricide of olfactory bulbectomized rats, but was 3.5, 8.8 and 225.5 times as potent as methamphetamine, imipramine and L-DOPA, respectively, in inhibiting THC-induced reversible muricide in rats. 5) amantadine at 50 mg/kg did not elicit circling behavior in the rat with unilateral nigral lesion induced by 6-hydroxydopamine. 6) Amantadine at high doses caused irritable aggression characterized by squealing in rats pretreated with intraventricular 6-hydroxydopamine. The most important characteristic of amantadine is its prominent effect suppressing the THC-induced catalepsy and muricide. This may be a reflection of the feature of amantadine activating the dopaminergic as well as the serotonergic systems.

AB - Behavioral effects of amantadine, especially on abnormal behavior in mice and rats, were reevaluated, in comparison with those of tricyclic antidepressants, methamphetamine and L-DOPA. 1) Amantadine at 10 ~ 50 mg/kg i.p., tended to decrease ambulation and rearing in rats and mice. The drug at 50 mg/kg i.p., caused piloerection and hyperirritability and at doses over 80 mg/kg, i.p., it impaired coordinated motor activity in rats. 2) Amantadine inhibited methamphetamine-induced hyperactivity, but apomorphine-induced stereotyped behavior was unaffected in rats. 3) Amantadine was equipotent to imipramine in suppressing haloperidol-induced catalepsy in rats, but L-DOPA was without effect. On the other hand, amantadine was 40 and 400 times as potent as imipramine and L-DOPA, respectively, in suppressing Δ9-tetrahydrocannabinol (THC)-induced catalepsy in rats. 4) Amantadine was as potent as imipramine in suppressing the muricide of olfactory bulbectomized rats, but was 3.5, 8.8 and 225.5 times as potent as methamphetamine, imipramine and L-DOPA, respectively, in inhibiting THC-induced reversible muricide in rats. 5) amantadine at 50 mg/kg did not elicit circling behavior in the rat with unilateral nigral lesion induced by 6-hydroxydopamine. 6) Amantadine at high doses caused irritable aggression characterized by squealing in rats pretreated with intraventricular 6-hydroxydopamine. The most important characteristic of amantadine is its prominent effect suppressing the THC-induced catalepsy and muricide. This may be a reflection of the feature of amantadine activating the dopaminergic as well as the serotonergic systems.

UR - http://www.scopus.com/inward/record.url?scp=0021959864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021959864&partnerID=8YFLogxK

M3 - Article

C2 - 2989132

AN - SCOPUS:0021959864

VL - 85

SP - 259

EP - 274

JO - Nihon yakurigaku zasshi. Folia pharmacologica Japonica

JF - Nihon yakurigaku zasshi. Folia pharmacologica Japonica

SN - 0015-5691

IS - 4

ER -